| Trial ID: | L0987 |
| Source ID: | NCT00524199
|
| Associated Drug: |
Mesna
|
| Title: |
Effects of Mesna on Homocysteine in Kidney Failure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: Mesna|OTHER: Saline
|
| Outcome Measures: |
Primary: Difference in plasma total homocysteine between placebo and mesna treatments, Four weeks | Secondary: Excretion of mesna during hemodialysis, duration of dialytic session
|
| Sponsor/Collaborators: |
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Collaborators: Canadian Institutes of Health Research (CIHR)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-03
|
| Completion Date: |
2007-06
|
| Results First Posted: |
|
| Last Update Posted: |
2018-11-06
|
| Locations: |
London Health Sciences Centre, London, Ontario, N6A 5A5, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00524199
|
